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Short communication
Pyruvate kinase in human amniotic fluid — a new indicator of fetal
maturity in late pregnancy
G. Bacigalupo, R. Meraner
Unit of Perinatal Medicine, Free University of Berlin, FRG
In the search for new clinically applicable parame- determination becomes in this way specific for
ters for the prenatal assessment of fetal maturity, pyruvate kinase.
we examined the pyruvate kinase activity in Seventy-three amniotic fluid samples were exam-
amniotic fluid samples. The enzyme was dis- ined (Tab. I); they contained neither meconium
covered in the thirties by LOHMANN and MEYER- nor blood. Amniotic fluid was obtained by trans-
HOF [2,4]. Pyruvate kinase [PK] (ATP: pyruvate abdominal ultrasound-directed amniocentesis. At
2-O-phosphotransferase, E.G. 2.7.1.40) transfers term (37-42 weeks of gestation) the fluid was
the energy-rich phosphate bond of phosphoenol- obtained by transcervical amniocentesis at the
pyruvate to ADP under formation of ATP and onset of labor. Since PK in vitro is labile, the sam-
pyruvate. As an enzyme of glycolysis PK is chiefly pies were centrifuged at 2° to 4°C immediately
present in the cytoplasma. after withdrawal, and the supernatant was sub-
We measured PK activity in a reaction coupled sequently processed.
with lactate dehydrogenase by the decrease of During the second trimester and up to the 33rd
NADH absorbance per time interval, whereby the gestational week, we could only measure slight PK
converted quantity of phosphoenolpyruvate or activities in amniotic fluid. In half of the cases no
pyruvate and the NADH decrease are synchronized PK activity was detectable at all. From the 34th
[1]. Interfering glycolytic metabolites are elimi- week to the 36th week of gestation a discrete PK
nated prior to the PK reaction; the reaction com- increase was observed; the maximal level recorded
mences only after addition of ADP solution. The was below 7 U/L.
Tab. I. Pyruvate kinase activity in amniotic fluid. 90% C.L. = 90% confidence limits, range between 5th and 95th per-
centiles.
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At term (37 to 42 weeks) a very steep rise in
amniotic fluid pyruvate kinase could be noticed;
only a small proportion of values (6 out of 36) lay
below 7U/L. There was a significant positive
correlation between PK values and amniocrit
values (p < 0.05; r = 0.35, v = 34). (The amniocrit
represents the proportion of cellular constituents
in amniotic fluid (v/v), expressed as percentage.)
No PK activity was found in 20 meconium-stained
amniotic fluid samples. Addition of meconium to
amniotic fluid samples with previously present PK
activity led to a disappearance of the enzyme
activity.
The first postnatal urine from newborns contained
no PK or only a trace of the enzyme. The pyruvate
kinase activity in amniotic fluid and that in the
plasma of umbilical vpnous blood of the same
neonates did not correlate.
Supplementary studies on the origin of the
enzyme in amniotic fluid produced in essence the
following results. By means of artificial in vitro
cytolysis in amniotic fluid sediments, additional
PK activity could be liberated. Considerable PK
activity was detectable in tracheal secretions of
therapeutically intubated newborn infants. Thus,
the presumable main sources of the enzyme in
amniotic fluid are the epithelium cells of the skin^
the respiratory tract and the amnion [3].
According to the results of this pilot study and
particularly in view of the rapid PK rise "at term",
assay of amniotic fluid pyruvate kinase appears to
be of clinical importance as an additional indicator
of fetal maturity in the perinatal period.
Summary
During the second and third trimesters increasing activ-
ities of the glycolytic enzyme pyruvate kinase are to be
found in human amniotic fluid. At term (37 to 42 weeks),
a very steep rise in amniotic fluid pyruvate kinase can be
noticed, which may serve as an additional prenatal indica-
tor of fetal maturity.
The presumable main sources of the enzyme in amniotic
fluid are the epithelium cells of the skin, the respiratory
tract and the amnion. In meconium stained amniotic fluid
no pyruvate kinase activity is detectable. Addition of
meconium to amniotic fluid samples with previously
present pyruvate kinase activity leads to a disappearance
of the enzyme activity.
Keywords: Amniotic fluid, fetal maturity, pyruvate kinase.
Zusammenfassung
Pyruvat-Kinase in menschlichem Fruchtwasser — ein
neuer Indikator der Fetalreife in der Spätschwangerschaft
In menschlichem Fruchtwasser aus dem zweiten und
dritten Trimenon sind steigende Aktivitäten des Glyko-
lyse-Enzyms Pyruvat-Kinase nachzuweisen. Am Termin
(SSW 37 bis 42) ist ein sehr Steuer Anstieg der Pyruvat-
Kinase-Aktivität zu beobachten, der als zusätzlicher
pränataler Indikator des fetalen Reifungsgrades dienen
kann.
Schlüsselwörter: Fetalreife, Fruchtwasser, Pyruvat-Kinase.
Die vermutlichen Hauptquellen des Enzyms im Frucht-
wasser sind die Epithelzellen der Haut, der Luftwege und
des Amnions.
In mekoniumhaltigen Fruchtwasser-Proben ist keine
Pyruvat-Kinase-Aktivität nachweisbar. Zusatz von Meko-
nium zu Fruchtwasser mit vorher vorhandener Pyruvat-
Kinase-Aktivität führt zum Verschwinden der Enzym-
Aktivität.
Resume
La pyruvate kinase dans le liquide amniotique humain:
Un nouvel indicateur de la maturite foetale en fin de
grossesse.
On a trouve une augmentation de Factivite de la pyruvate
kinase, enzyme de la glycolyse, dans le liquide amniotique
humain au cours du 2eme et du 3eme trimestre. A terme
(37 ä 42 semaines) on peut remarquer une elevation tres
notable de la pyruvate kinase amniotique, qui peut servir
comme indicateur prenatal supplemental de la maturite
foetale.
Les cellules epitheliales cutanees, l'arbre respkatoire et
Famnios sont les sources principals supposees de
Fenzyme du liquide amniotique. On ne peut detecter
d'activite pyruvate kinase dans les liquides meconiaux.
L'addition de meconium ä des liquides possedant aupara-
vant une activite pyruvate kinase entraine la disparition
de Factivite enzymatique.
Mots-cles: Liquide amniotique, maturite foetale, pyruvate kinase.
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